These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 1376635)
1. A 35 kDa Fos-related antigen is co-localized with substance P and dynorphin in striatal neurons. Zhang WQ; Pennypacker KR; Ye H; Merchenthaler IJ; Grimes L; Iadarola MJ; Hong JS Brain Res; 1992 Apr; 577(2):312-7. PubMed ID: 1376635 [TBL] [Abstract][Full Text] [Related]
2. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. Gerfen CR; McGinty JF; Young WS J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092 [TBL] [Abstract][Full Text] [Related]
3. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies. Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858 [TBL] [Abstract][Full Text] [Related]
5. Prolonged and selective induction of Fos-related antigen(s) in striatal neurons after 6-hydroxydopamine lesions of the rat substantia nigra pars compacta. Dragunow M; Leah JD; Faull RL Brain Res Mol Brain Res; 1991 Jul; 10(4):355-8. PubMed ID: 1681407 [TBL] [Abstract][Full Text] [Related]
6. Interaction between the serotoninergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons. Gardier AM; Moratalla R; Cuéllar B; Sacerdote M; Guibert B; Lebrec H; Graybiel AM J Neurochem; 2000 Apr; 74(4):1363-73. PubMed ID: 10737591 [TBL] [Abstract][Full Text] [Related]
7. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. Steiner H; Gerfen CR J Neurosci; 1993 Dec; 13(12):5066-81. PubMed ID: 7504719 [TBL] [Abstract][Full Text] [Related]
8. The distribution of dynorphinergic terminals in striatal target regions in comparison to the distribution of substance P-containing and enkephalinergic terminals in monkeys and humans. Reiner A; Medina L; Haber SN Neuroscience; 1999; 88(3):775-93. PubMed ID: 10363817 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the concentration of dynorphin A1-8 in the striatonigral pathway by the dopaminergic system. Li S; Sivam SP; Hong JS Brain Res; 1986 Nov; 398(2):390-2. PubMed ID: 2879611 [TBL] [Abstract][Full Text] [Related]
10. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Besson MJ; Graybiel AM; Quinn B Neuroscience; 1990; 39(1):33-58. PubMed ID: 1708467 [TBL] [Abstract][Full Text] [Related]
11. Identification of a subpopulation of substantia nigra pars compacta gamma-aminobutyric acid neurons that is regulated by basal ganglia activity. Hebb MO; Robertson HA J Comp Neurol; 2000 Jan; 416(1):30-44. PubMed ID: 10578101 [TBL] [Abstract][Full Text] [Related]
12. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat. Tan DP; Tsou K Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993 [TBL] [Abstract][Full Text] [Related]
13. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Jiang HK; McGinty JF; Hong JS Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976 [TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
15. The effects of dopamine D-1 and D-2 receptor subtype agonists on nigrostriatal opioid dynorphin and enkephalin immunostaining in 6-hydroxydopamine lesioned rats. Jiang HK; Wang JY Chin J Physiol; 1991; 34(4):413-25. PubMed ID: 1687937 [TBL] [Abstract][Full Text] [Related]
17. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats. Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109 [TBL] [Abstract][Full Text] [Related]
18. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors. Reid MS; O'Connor WT; Herrera-Marschitz M; Ungerstedt U Brain Res; 1990 Jun; 519(1-2):255-60. PubMed ID: 1975763 [TBL] [Abstract][Full Text] [Related]
19. Apomorphine induction of AP-1 DNA binding in the rat striatum after dopamine depletion. Pennypacker KR; Zhang WQ; Ye H; Hong JS Brain Res Mol Brain Res; 1992 Sep; 15(1-2):151-5. PubMed ID: 1331662 [TBL] [Abstract][Full Text] [Related]
20. Nigrostriatal dopamine mediates the stimulatory effects of corticotropin releasing factor on methionine-enkephalin and dynorphin release from the rat neostriatum. Sirinathsinghji DJ; Nikolarakis KE; Reimer S; Herz A Brain Res; 1990 Aug; 526(1):173-6. PubMed ID: 1981853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]